Nathan Rice
Stock Analyst at Piper Sandler
(3.09)
# 1,192
Out of 5,148 analysts
61
Total ratings
52.63%
Success rate
11.35%
Average return
Main Sectors:
Stocks Rated by Nathan Rice
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BFC Bank First | Maintains: Neutral | $142 → $150 | $138.07 | +8.64% | 10 | Jan 26, 2026 | |
| FMBH First Mid Bancshares | Maintains: Overweight | $49 → $48 | $41.50 | +15.66% | 5 | Nov 3, 2025 | |
| MBIN Merchants Bancorp | Maintains: Overweight | $41 → $42 | $43.36 | -3.14% | 9 | Oct 30, 2025 | |
| BY Byline Bancorp | Maintains: Overweight | $34 → $35 | $31.80 | +10.06% | 9 | Oct 28, 2025 | |
| CVS CVS Health | Maintains: Buy | $85 → $74 | $81.66 | -9.38% | 2 | May 2, 2024 | |
| NIC Nicolet Bankshares | Assumes: Neutral | $84 | $156.04 | -46.17% | 1 | Jan 10, 2024 | |
| ALGN Align Technology | Downgrades: Sell | $197 | $189.02 | +4.22% | 10 | Dec 11, 2023 | |
| ELAN Elanco Animal Health | Maintains: Sell | $11 → $9 | $26.09 | -65.50% | 1 | Apr 25, 2023 | |
| IDXX IDEXX Laboratories | Upgrades: Buy | $530 → $435 | $636.70 | -31.68% | 4 | Jul 21, 2022 | |
| CI The Cigna Group | Initiates: Neutral | $233 | $290.85 | -19.89% | 5 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $83 | $44.60 | +86.10% | 4 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $15 | $19.90 | -24.62% | 1 | Dec 19, 2019 |
Bank First
Jan 26, 2026
Maintains: Neutral
Price Target: $142 → $150
Current: $138.07
Upside: +8.64%
First Mid Bancshares
Nov 3, 2025
Maintains: Overweight
Price Target: $49 → $48
Current: $41.50
Upside: +15.66%
Merchants Bancorp
Oct 30, 2025
Maintains: Overweight
Price Target: $41 → $42
Current: $43.36
Upside: -3.14%
Byline Bancorp
Oct 28, 2025
Maintains: Overweight
Price Target: $34 → $35
Current: $31.80
Upside: +10.06%
CVS Health
May 2, 2024
Maintains: Buy
Price Target: $85 → $74
Current: $81.66
Upside: -9.38%
Nicolet Bankshares
Jan 10, 2024
Assumes: Neutral
Price Target: $84
Current: $156.04
Upside: -46.17%
Align Technology
Dec 11, 2023
Downgrades: Sell
Price Target: $197
Current: $189.02
Upside: +4.22%
Elanco Animal Health
Apr 25, 2023
Maintains: Sell
Price Target: $11 → $9
Current: $26.09
Upside: -65.50%
IDEXX Laboratories
Jul 21, 2022
Upgrades: Buy
Price Target: $530 → $435
Current: $636.70
Upside: -31.68%
The Cigna Group
Dec 14, 2021
Initiates: Neutral
Price Target: $233
Current: $290.85
Upside: -19.89%
Dec 14, 2021
Initiates: Neutral
Price Target: $83
Current: $44.60
Upside: +86.10%
Dec 19, 2019
Initiates: Overweight
Price Target: $15
Current: $19.90
Upside: -24.62%